Cidara Therapeutics
Stock Forecast, Prediction & Price Target
Cidara Therapeutics Financial Estimates
Cidara Therapeutics Revenue Estimates
Cidara Therapeutics EBITDA Estimates
Cidara Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $49.57M N/A | $64.28M 29.68% | $63.90M -0.59% | Avg: $42.85M Low: $39.24M High: $46.46M avg. -32.93% | Avg: $53.24M Low: $48.75M High: $57.73M avg. 24.23% | Avg: $138.05M Low: $126.42M High: $149.68M avg. 159.28% | Avg: $104.97M Low: $96.12M High: $113.81M avg. -23.96% |
Net Income
% change YoY
| $-43.90M N/A | $-29.79M 32.13% | $-22.93M 23.04% | Avg: $-39.42M Low: $-37.89M High: $55.21M avg. -71.94% | Avg: $-33.31M Low: $-33.65M High: $82.40M avg. 15.49% | Avg: $47.12M Low: $41.96M High: $52.28M avg. 241.43% | Avg: $24.08M Low: $21.44M High: $26.72M avg. -48.88% |
EBITDA
% change YoY
| $-42.25M N/A | $-29.71M 29.66% | $-24.36M 18.01% | Avg: $-31.67M Low: $-34.34M High: $-29.01M avg. -30.02% | Avg: $-39.35M Low: $-42.67M High: $-36.04M avg. -24.23% | Avg: $-102.04M Low: $-110.64M High: $-93.45M avg. -159.28% | Avg: $-77.59M Low: $-84.13M High: $-71.05M avg. 23.96% |
EPS
% change YoY
| -$16.75 N/A | -$8.53 49.07% | -$5.25 38.45% | Avg: $0.51 Low: -$8.67 High: $12.63 avg. 109.65% | Avg: $3.17 Low: -$7.7 High: $18.85 avg. 526.31% | Avg: $10.78 Low: $9.6 High: $11.96 avg. 239.70% | Avg: $5.51 Low: $4.91 High: $6.11 avg. -48.88% |
Operating Expenses
% change YoY
| $91.82M N/A | $94.00M 2.37% | $86.86M -7.59% | Avg: $26.11M Low: $23.91M High: $28.31M avg. -69.93% | Avg: $32.44M Low: $29.70M High: $35.17M avg. 24.23% | Avg: $84.11M Low: $77.02M High: $91.20M avg. 159.28% | Avg: $63.95M Low: $58.56M High: $69.34M avg. -23.96% |
FAQ
What is Cidara Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.02% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -37.89M, average is -39.42M and high is 55.21M.
What is Cidara Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 31.65% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $39.24M, average is $42.85M and high is $46.46M.
What is Cidara Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 206.69% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$8.67, average is $0.51 and high is $12.63.